Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LOW MOLECULAR WEIGHT HEPARIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 535 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Greer, IA; Thomson, AJ
      Management of venous thromboembolism in pregnancy

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    2. Alpert, JS; Budaj, AJ; Gurfinkel, EP; Henry, TD
      Issues in antithrombin therapy for UA/NSTEMI

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    3. Samama, CM
      Venous thromboembolism deserves your attention

      CRITICAL CARE
    4. Bell, GK; Goldhaber, SZ
      Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

      VASCULAR MEDICINE
    5. Glueck, CJ; Freiberg, RA; Fontaine, RN; Sieve-Smith, L; Wang, P
      Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Nicholson, CD; Lensing, AWA
      Old antithrombotics: ready to retire?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    7. Logason, K; Bergqvist, D
      Low molecular weight heparin (enoxaparin) versus dextran in the preventionof early occlusion following arterial bypass surgery distal to the groin

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    8. Kher, A; Samama, MM
      Low-molecular-weight heparins: Weeks or months instead of days of treatment

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    9. Cella, G; Sbarai, A; Mazzaro, G; Motta, G; Carraro, P; Andreozzi, GM; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor release induced by defibrotide and heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    10. Demir, M; Iqbal, O; Hoppensteadt, DA; Piccolo, P; Ahmad, S; Schultz, CL; Linhardt, RJ; Fareed, J
      Anticoagulant and antiprotease profiles of a novel natural heparinomimeticmannopentaose phosphate sulfate (PI-88)

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    11. Kupferminc, MJ; Fait, G; Many, A; Lessing, JB; Yair, D; Bar-Am, A; Eldor, A
      Low-molecular-weight heparin for the prevention of obstetric complicationsin women with thrombophilias

      HYPERTENSION IN PREGNANCY
    12. Schwarz, T; Schmidt, B; Beyer, J; Schellong, SM
      Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin

      BLOOD COAGULATION & FIBRINOLYSIS
    13. Bendz, B; Sevre, K; Andersen, TO; Sandset, PM
      Low molecular weight heparin prevents activation of coagulation in a hypobaric environment

      BLOOD COAGULATION & FIBRINOLYSIS
    14. Eldor, A
      Thrombophilia and its treatment in pregnancy

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    15. Heit, JA
      Perioperative management of the chronically anticoagulated patient

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    16. Choo, JK; Kereiakes, DJ
      Low molecular weight heparin therapy for percutaneous coronary intervention: A practice in evolution

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    17. Krotenberg, R; Adler, U; Pomeranz, B; Miller, JD; Russell, MW
      Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty - A retrospective analysis

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    18. Wirth, T; Schneider, B; Misselwitz, F; Lomb, M; Tuylu, H; Egbring, R; Griss, P
      Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial

      ARTHROSCOPY
    19. Burg, MD; Dallara, JJ
      Rupture of a previously normal spleen in association with enoxaparin: An unusual cause of shock

      JOURNAL OF EMERGENCY MEDICINE
    20. Mitragotri, S; Kost, J
      Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound

      PHARMACEUTICAL RESEARCH
    21. Thanou, M; Verhoef, JC; Nihot, MT; Verheijden, JHM; Junginger, HE
      Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol (R) 934P

      PHARMACEUTICAL RESEARCH
    22. Neagu, M; Manda, G; Constantin, C; Tanaseanu, C; Mikhailidis, DP
      The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular disease

      INTERNATIONAL ANGIOLOGY
    23. Lai, KN; Ho, K; Cheung, RCK; Lit, LCW; Lee, SKM; Fung, KS; Tong, MKL; Lam, CWK
      Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    24. Vila, V; Martinez-Sales, V; Reganon, E; Peris, E; Perez, F; Ruano, M; Aznar, J
      Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes

      HAEMATOLOGICA
    25. Momi, S; Nasimi, M; Colucci, M; Nenci, GP; Gresele, P
      Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition

      HAEMATOLOGICA
    26. Grau, E; Tenias, JM; Real, E; Medrano, J; Ferrer, R; Pastor, E; Selfa, S
      Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

      AMERICAN JOURNAL OF HEMATOLOGY
    27. Busby, LT; Weyman, A; Rodgers, GM
      Excessive anticoagulation in patients with mild renal insufficiency receiving long-term therapeutic enoxaparin

      AMERICAN JOURNAL OF HEMATOLOGY
    28. Schreiber, C; Augustin, N; Holper, K; Lange, R
      Thrombosis of a mechanical prosthetic heart valve after inadequate anticoagulation with low-molecular-weight heparin

      HERZ
    29. Couturaud, F; Julian, JA; Kearon, C
      Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism - A meta-analysis

      THROMBOSIS AND HAEMOSTASIS
    30. Salvioni, A; Casilli, F; Assanelli, E; Grazi, M; Marenzi, G; Guazzi, MD
      Comparison of enoxaparin and unfractionated heparin on thrombin generationin acute coronary syndromes without ST-segment elevation

      THROMBOSIS AND HAEMOSTASIS
    31. Eldor, A
      Thrombophilia, thrombosis and pregnancy

      THROMBOSIS AND HAEMOSTASIS
    32. Prandoni, P
      Heparins and venous thromboembolism: Current practice and future directions

      THROMBOSIS AND HAEMOSTASIS
    33. Brown, JR; Kuter, DJ
      The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients

      THROMBOSIS AND HAEMOSTASIS
    34. Schambeck, CM; Eberl, E; Geisen, U; Grossmann, R; Keller, F
      The impact of dalteparin (Fragmin (R)) on thrombin generation in pregnant women with venous thromboembolism: Significance of the factor V Leiden mutation

      THROMBOSIS AND HAEMOSTASIS
    35. Alban, S; Gastpar, R
      Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins

      THROMBOSIS AND HAEMOSTASIS
    36. Schick, BP; Gradowski, JF; San Antonio, JD; Martinez, J
      Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans

      THROMBOSIS AND HAEMOSTASIS
    37. Higginbotham, EA; Zimmerman, SA; Howard, TA; Schanberg, L; Kredich, D; Ware, RE
      Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus

      JOURNAL OF RHEUMATOLOGY
    38. Richter, C; Sitzmann, J; Lang, P; Weitzel, H; Huch, A; Huch, R
      Excretion of low molecular weight heparin in human milk

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    39. Lin, PH; Sinha, U; Betz, A
      Antithrombin binding of low molecular weight heparins and inhibition of factor Xa

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    40. Partsch, H
      Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation

      VASA-JOURNAL OF VASCULAR DISEASES
    41. Wilson, SJ; Wilbur, K; Burton, E; Anderson, DR
      Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism

      HAEMOSTASIS
    42. Bonnet, F; Morlat, P; de Witte, S; Bernard, N; Lacoste, D; Beylot, J
      Bleeding events of low molecular weight heparins: 15 cases

      REVUE DE MEDECINE INTERNE
    43. Pottier, P; Blanchon, B; Pistorius, MA; Grolleau, JY
      Risk factors and incidence of venous thromboembolism in internal medicine:a prospective study on 947 in patients

      REVUE DE MEDECINE INTERNE
    44. Pautas, E; Siguret, V; d'Urso, M; Laurent, M; Gaussem, P; Fevrier, M; Durand-Gasselin, B
      Monitoring of tinzaparin treatment at treatment dose of 10 days in elderlypatients

      REVUE DE MEDECINE INTERNE
    45. Carmoi, T; Skopinski, S; Constans, J; Vahedy, A; Conri, C
      Priapism and low molecular-weight heparin: case report

      REVUE DE MEDECINE INTERNE
    46. Mirow, N; Minami, K; KLeikamp, G; Tenderich, G; Puhlmann, T; Korfer, R
      Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting

      THORACIC AND CARDIOVASCULAR SURGEON
    47. Thanou, M; Verhoef, JC; Junginger, HE
      Oral drug absorption enhancement by chitosan and its derivatives

      ADVANCED DRUG DELIVERY REVIEWS
    48. Collet, JP; Montalescot, G; Choussat, R; Lison, L; Ankri, A
      Enoxaparin in unstable angina patients with renal failure

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    49. Husted, S; Becker, R; Kher, A
      A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease

      CLINICAL CARDIOLOGY
    50. Kontny, F
      Improving outcomes in acute coronary syndromes - The FRISC II trial

      CLINICAL CARDIOLOGY
    51. Fry, ETA
      Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

      CLINICAL CARDIOLOGY
    52. Wallentin, L; Dellborg, M; Lindahl, B; Nilsson, T; Pehrsson, K; Swahn, E
      The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS study

      CLINICAL CARDIOLOGY
    53. Camm, AJ
      Atrial fibrillation: Is there a role for low-molecular-weight heparin?

      CLINICAL CARDIOLOGY
    54. Reach, I; Luong, N; Chastang, C; Chakroun, M; Mirshahi, S; Mirshahi, MC; Soria, J; Desmichels, D; Baumelou, A
      Dose effect relationship of reviparin in chronic hemodialysis: A crossoverstudy versus nadroparin

      ARTIFICIAL ORGANS
    55. Mirow, N; Brinkmann, T; Minami, K; Tenderich, G; Kleesiek, K; Korfer, R
      Heparin-coated extracorporeal circulation with full and low dose heparinization: Comparison of thrombin related coagulatory effects

      ARTIFICIAL ORGANS
    56. Rose, P; Bell, D; Green, ES; Davenports, A; Fegan, C; Grech, H; O'Shaughnessy, D; Voke, J
      The outcome of ambulatory DVT management using a multidisciplinary approach

      CLINICAL AND LABORATORY HAEMATOLOGY
    57. Sissi, C; Naggi, A; Torri, G; Palumbo, M
      Effects of sulfation on antithrombin-thrombin/factor Xa interactions in semisynthetic low molecular weight heparins

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    58. Bretschneider, E; Schror, K
      Cellular effects of factor Xa on vascular smooth muscle cells - Inhibitionby heparins?

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    59. Kaiser, P; Harenberg, J; Walenga, JM; Huhle, G; Giese, C; Prechel, M; Hoppensteadt, D; Fareed, J
      Effects of a heparin-binding protein on blood coagulation and platelet function

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    60. Harenberg, J; Huisman, MV; Tolle, AR; Breddin, HK; Kirchmaier, CM
      Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    61. Boneu, B; de Moerloose, P
      How and when to monitor a patient treated with low molecular weight heparin

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    62. Prisco, D; Falciani, M; Antonucci, E; Gensini, GF
      Hirudins for prophylaxis and treatment of venous thromboembolism

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    63. Shorr, AF; Ramage, AS
      Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications

      CRITICAL CARE MEDICINE
    64. Selby, R; Geerts, WH
      Venous thromboembolism prophylaxis after trauma: Dollars and sense

      CRITICAL CARE MEDICINE
    65. Goldhaber, SZ
      Unsolved issues in the treatment of pulmonary embolism

      THROMBOSIS RESEARCH
    66. Lee, AYY
      Treatment of venous thromboembolism in cancer patients

      THROMBOSIS RESEARCH
    67. Koch, A; Ziegler, S; Breitschwerdt, H; Victor, N
      Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data

      THROMBOSIS RESEARCH
    68. Horlocker, TT
      Low molecular weight heparin and neuraxial anesthesia

      THROMBOSIS RESEARCH
    69. Hull, RD; Pineo, GF; MacIsaac, S
      Low-molecular-weight heparin prophylaxis: Preoperative versus postoperative initiation in patients undergoing elective hip surgery

      THROMBOSIS RESEARCH
    70. Heit, JA
      Low-molecular-weight heparin: The optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement

      THROMBOSIS RESEARCH
    71. Bazzan, M; Donvito, V
      Low-molecular-weight heparin during pregnancy

      THROMBOSIS RESEARCH
    72. Klein-Weigel, P; Fraedrich, G
      Conservative treatment of acute deep vein thrombosis of the lower extremity

      ZENTRALBLATT FUR CHIRURGIE
    73. Lohmann, U; Glaser, E; Braun, BE; Botel, U
      Prevention of deep-vein thrombosis and pulmonary embolism after spinal fracture with acute spinal cord injury. Comparison of low-molecular-weight heparin and unfractionated heparin

      ZENTRALBLATT FUR CHIRURGIE
    74. Janni, W; Bergauer, F; Rjosk, D; Lohscheidt, K; Hagena, FW
      A randomized controlled study evaluating the safety and efficacy of different low molecular weight heparins for high risk patients

      ZENTRALBLATT FUR CHIRURGIE
    75. Vrij, AA; Jansen, JM; Schoon, EJ; de Bruine, A; Hemker, HC; Stockbrugger, RW
      Low molecular weight heparin treatment in steroid refractory ulcerative colitis: Clinical outcome and influence on mucosal capillary thrombi

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    76. van Haren, FMP; Ruiter, DJ; Hilbrands, LB
      Nadroparin-induced calcinosis cutis in renal transplant recipients

      NEPHRON
    77. Benchetrit, S; Golan, E; Podjarny, E; Green, J; Rashid, G; Bernheim, J; Hershkovitz, R; Bernheim, J
      Low molecular weight heparin reduces proteinuria and modulates glomerular TNF-alpha production in the early phase of adriamycin nephropathy

      NEPHRON
    78. Sarto, A; Rocha, M; Geller, M; Capmany, C; Martinez, M; Quintans, C; Donaldson, M; Pasqualini, RS
      Treatment with enoxaparin adapted to the fertility program in women with early recurrent pregnancy loss and thrombophilia.

      MEDICINA-BUENOS AIRES
    79. Thanou, M; Nihot, MT; Jansen, M; Verhoef, JC; Junginger, HE
      Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative,enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo

      JOURNAL OF PHARMACEUTICAL SCIENCES
    80. Mirow, N; Brinkmann, T; Minami, K; Tenderich, G; Schulte-Eistrup, S; Kleesiek, K; Korfer, R
      Low dose systemic heparinization combined with heparin-coated extracorporeal circulation - Effects related to platelets

      JOURNAL OF CARDIOVASCULAR SURGERY
    81. Kuzu, N; Ucar, H
      The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin

      INTERNATIONAL JOURNAL OF NURSING STUDIES
    82. Hamel, E; Pacouret, G; Vincentelli, D; Forissier, JF; Peycher, P; Pottier, JM; Charbonnier, B
      Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation - Results from a 128-patient monocenter registry

      CHEST
    83. Taille, C; Fartoukh, M; Houel, R; Kobeiter, H; Remy, P; Lemaire, F
      Spontaneous hemomediastinum complicating steroid-induced mediastinal lipomatosis

      CHEST
    84. Bisio, A; De Ambrosi, L; Gonella, S; Guerrini, M; Guglieri, S; Maggia, G; Torri, G
      Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    85. Rowan, JA; McCowan, LME; Raudkivi, PJ; North, RA
      Enoxaparin treatment in women with mechanical heart valves during pregnancy

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    86. Fausett, MB; Vogtlander, M; Lee, RM; Esplin, MS; Branch, DW; Rodgers, GM; Silver, RM
      Heparin-induced thrombocytopenia is rare in pregnancy

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    87. Davis, JD
      Prevention, diagnosis, and treatment of venous thromboembolic complications of gynecologic surgery

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    88. Antman, EM
      Enoxaparin: a new standard of care

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    89. Grines, CL; Kereiakes, D
      Antithrombotic therapy in the catheterization laboratory: interim analysisof the NICE trials

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    90. Bernink, PJLM
      Restoring patency in acute myocardial infarction: the role of low-molecular-weight heparins

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    91. Ageno, W; Turpie, AGG
      Therapy of unstable angina with the low molecular weight heparins

      VASCULAR MEDICINE
    92. Nenci, GG; Minciotti, A
      Low molecular weight heparins for arterial thrombosis

      VASCULAR MEDICINE
    93. Ramos, CM; Pastor, AL; Pena, JRN; de Gopegui, NR; Lopez, RS; Jorgensen, T; Pastor, L; Tamames, ES
      Laboratory evaluation of the effect of prophylaxis for thromboembolism with fractionated heparin in patients undergoing laparoscopic cholecystectomy

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    94. Punzalan, RC; Hillery, CA; Montgomery, RR; Scott, JP; Gill, JC
      Low-molecular-weight heparin in thrombotic disease in children and adolescents

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    95. Gerbutavicius, R; Iqbal, O; Messmore, H; Hoppensteadt, DA; Demir, M; Khan, E; Bacher, P; Fareed, J
      Differential effects of unfractionated heparin and low-molecular-weight heparins on tissue thromboplastin inhibition test

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    96. Lassen, MR; Borris, LC; Jensen, HP; Poulsen, KA; Ejstrud, P; Andersen, BS
      Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    97. Morris, TA
      Low molecular weight heparins: Background and pharmacology

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    98. Tapson, VF
      Treatment of acute deep venous thrombosis and pulmonary embolism: Use of low molecular weight heparin

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    99. Goldhaber, SZ
      The approach to massive pulmonary embolism

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    100. Mathis, AS
      Newer antithrombotic strategies in the initial management of non-ST-Segment elevation acute coronary syndromes

      ANNALS OF PHARMACOTHERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 11:22:07